Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Virology

• Publication date

  2005-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VIROL.2005.06.006PMID 15996702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003

  2004cited by this paper
• Protection of mice with recombinant influenza virus neuraminidase.

  2004cited by this paper
• Update: influenza activity--United States, 2003-04 season.

  2004cited by this paper
• Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains.

  2003cited by this paper
• Update: influenza activity--United States, 2003-04 season.

  2003cited by this paper
• Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition.

  2002cited by this paper
• Egg-adapted replication-restricted virus protects mice against lethal influenza.

  2000cited by this paper
• Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

  2000cited by this paper
• Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.

  1999cited by this paper
• Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.

  1999cited by this paper
• Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.

  1998cited by this paper
• Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults

  1996cited by this paper
• Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.

  1996cited by this paper
• Preparation and characterization of a purified influenza virus neuraminidase vaccine.

  1995cited by this paper
• Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.

  1995cited by this paper
• Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants.

  1995cited by this paper
• A review of attenuation of influenza viruses by genetic manipulation.

  1995cited by this paper
• Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition

  1993cited by this paper
• Advances in Influenza Virus Vaccine Research a

  1993cited by this paper
• Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.

  1990cited by this paper
• Cold-adapted influenza viruses for use as live vaccines for man.

  1990cited by this paper
• Cold-adapted influenza viruses for use as live vaccines for man.

  1990cited by this paper
• Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.

  1990cited by this paper
• Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection

  1989cited by this paper
• Complementation of recombinant baculoviruses by coinfection with wild-type virus facilitates production in insect larvae of antigenic proteins of hepatitis B virus and influenza virus.

  1989cited by this paper
• Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.

  1987cited by this paper
• Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.

  1987cited by this paper
• Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.

  1987cited by this paper
• Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.

  1987cited by this paper
• Influenza vaccination in the elderly: 1. Determinants of acceptance.

  1985cited by this paper
• Influenza: viral determinants of the pathogenicity and epidemicity of an invariant disease of variable occurrence.

  1980cited by this paper
• Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations.

  1980cited by this paper
• Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths.

  1980cited by this paper
• Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations.

  1977cited by this paper
• A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children.

  1977cited by this paper
• Induction of partial immunity to influenza by a neuraminidase-specific vaccine.

  1974cited by this paper
• Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.

  1971cited by this paper
• Viruses in families.

  1971cited by this paper
• COMPARISONS OF SEROLOGIC AND FEBRILE RESPONSES IN HUMANS TO VACCINATION WITH INFLUENZA A VIRUSES OR THEIR HEMAGGLUTININS.

  1964cited by this paper
• Application of a microtechnique to viral serological investigations.

  1962cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• The recurrence of influenza A prime in a boarding school after 2 years.

  1950cited by this paper
• PERSISTENT ANTIGENIC VARIATION OF INFLUENZA A VIRUSES AFTER INCOMPLETE NEUTRALIZATION IN OVO WITH HETEROLOGOUS IMMUNE SERUM

  1950cited by this paper

• A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine.

  2026cites this paper
• Fighting the flu in the tropics: The role of influenza vaccination in Southeast Asia

  2025cites this paper
• COBRA N2 NA vaccines induce protective immune responses against influenza viral infection

  2024cites this paper
• Immunogenicity of Inactivated H5 Avian Influenza Vaccine Used in Commercial Laying Pullet in Tehran Province, Iran.

  2024cites this paper
• Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines

  2024cites this paper
• Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States

  2024cites this paper
• Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza

  2023cites this paper
• Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States

  2023cites this paper
• Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets

  2023cites this paper
• Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination.

  2022cites this paper
• Nasal Administration of M2e/CpG-ODN Encapsulated in N-Trimethyl Chitosan (TMC) Significantly Increases Specific Immune Responses in a Mouse Model.

  2022cites this paper
• Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy

  2021cites this paper
• Design of the recombinant influenza neuraminidase antigen is crucial for protective efficacy

  2021cites this paper
• The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination

  2021cites this paper
• Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine

  2020cites this paper
• Recombinant baculovirus expressing the FrC-OVA protein induces protective antitumor immunity in an EG7-OVA mouse model

  2019cites this paper
• Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.

  2019cites this paper
• A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines

  2019cites this paper
• Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.

  2018cites this paper
• Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection.

  2018cites this paper
• Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype

  2018cites this paper
• Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines

  2018cites this paper
• Influenza Virus: Dealing with a Drifting and Shifting Pathogen

  2018cites this paper
• Towards a universal influenza vaccine: different approaches for one goal

  2018cites this paper
• Vaccination with Recombinant Baculovirus Expressing Ranavirus Major Capsid Protein Induces Protective Immunity in Chinese Giant Salamander, Andrias davidianus

  2017cites this paper
• Coimmunization with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H5N1 vaccine against heterologous virus.

  2017cites this paper
• Effects of PB1-F2 and PA-X on the pathogenicity of H1N1 influenza virus

  2017cites this paper
• Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.

  2017cites this paper
• Construction of recombinant baculoviruses expressing hemagglutinin of H5N1 avian influenza and research on the immunogenicity

  2016cites this paper
• Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.

  2016cites this paper
• Influenza virus neuraminidase (NA): a target for antivirals and vaccines

  2016cites this paper
• Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay

  2015cites this paper
• Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.

  2015cites this paper
• Plant molecular farming for the production of industrial enzyme and vaccines

  2015cites this paper
• Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice

  2015cites this paper
• A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 enhances cell-mediated immune response and longevity of the total IgG to influenza A virus M2e protein in mice.

  2015cites this paper
• Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase

  2015cites this paper
• Modulation of Innate Immune Responses by Influenza-Specific Ovine Polyclonal Antibodies Used for Prophylaxis

  2014cites this paper
• Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris

  2014cites this paper
• Influenza vaccines: from whole virus preparations to recombinant protein technology

  2014cites this paper
• Overview of Serological Techniques for Influenza Vaccine Evaluation : Past , Present and Future

  2014cites this paper
• Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.

  2014cites this paper
• Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future

  2014cites this paper
• Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.

  2014cites this paper
• Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012.

  2014cites this paper
• Revision note VETMIC-D-13-8580 Authors’ response to reviewer comments: Reviewer #1: This manuscript is a composite of two topics - one that relates to an enhanced surveillance program in the UK for equine influenza virus (and presumably

  2013cites this paper
• Recombinant therapeutic protein vaccines.

  2013cites this paper
• Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents

  2013cites this paper
• Developments of subunit and VLP vaccines against influenza a virus

  2012cites this paper
• Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution.

  2012cites this paper
• In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.

  2012cites this paper
• Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.

  2012cites this paper
• Virus-like particles as universal influenza vaccines

  2012cites this paper
• Correlates of vaccine protection from influenza and its complications

  2012cites this paper
• A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies.

  2012cites this paper
• Advances in the development of universal influenza vaccines

  2012cites this paper
• Expression of Insoluble Influenza Neuraminidase Type 1 (NA1) Protein in Tobacco

  2012cites this paper
• Comparing influenza virus hemagglutinin (HA) expression in three different baculovirus expression systems

  2012cites this paper
• Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir.

  2011cites this paper
• Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses

  2011cites this paper
• Influenza viral neuraminidase: the forgotten antigen

  2011cites this paper
• Antibodies Against Conserved Antigens Provide Opportunities for Reform in Influenza Vaccine Design

  2011cites this paper
• A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza.

  2011cites this paper
• Bio-Nanohybrid materials based on clays and phospholipids

  2011cites this paper
• Evaluation of antineuraminidase antibody in preclinical and clinical studies of seasonal trivalent live influenza vaccine

  2011cites this paper
• Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.

  2011cites this paper
• Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin

  2010cites this paper
• Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets

  2010cites this paper
• Influenza: a unique problem in vaccination

  2010cites this paper
• Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.

  2010cites this paper
• Influenza neuraminidase as a vaccine antigen.

  2009cites this paper
• Pandemic preparedness: toward a universal influenza vaccine.

  2009cites this paper
• Mouse Models of Influenza

  2009cites this paper
• Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles

  2009cites this paper
• WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008.

  2009cites this paper
• Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control

  2009cites this paper
• New strategies to overcome the drawbacks of currently available flu vaccines.

  2009cites this paper
• Recombinant proteins produced in insect cells.

  2009cites this paper
• Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro.

  2009cites this paper
• Vaccination: tipping the balance from pathogen to host.

  2008cites this paper
• Purification of Neuraminidase from Sub Type H5N1 Influenza Virus

  2008cites this paper
• A call to cellular & humoral arms: Enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A

  2008cites this paper
• Influenza vaccines and vaccination strategies in birds.

  2008cites this paper
• FluBlok, a recombinant influenza vaccine.

  2008cites this paper
• Special Topic: Progress and Challenges in Vaccinology Development of a Vaccine Against Pandemic Influenza Viruses: Current Status and Perspectives

  2008influential citation
• Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers

  2008cites this paper
• Recombinant Influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines

  2008cites this paper
• Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks

  2008cites this paper
• Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

  2008cites this paper
• Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.

  2008cites this paper
• Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.

  2007cites this paper
• Avian influenza viruses: a severe threat of a pandemic in children?

  2007cites this paper
• antigenes de la grippe, compositions de vaccins et procedes associes

  2007cites this paper
• Expression of the Severe Acute Respiratory Syndrome Coronavirus 3a Protein and the Assembly of Coronavirus-Like Particles in the Baculovirus Expression System

  2007cites this paper
• Changing perspective on immunization against influenza.

  2007cites this paper
• Influenza virus infections in mammals.

  2006cites this paper
• Variation in the divalent cation requirements of influenza A virus N1 neuraminidases.

  2006cites this paper
• Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

  2006cites this paper
• Development of recombinant protein-based influenza vaccine. Expression and affinity purification of H1N1 influenza virus neuraminidase.

  2006cites this paper
• Vaccines for Viral and Parasitic Diseases Produced with Baculovirus Vectors

  2006cites this paper